HOPE-B: Trial of AMT-061 in Severe or Moderately Severe Hemophilia B Patients
NCT03569891
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
67
Enrollment
INDUSTRY
Sponsor class
Conditions
Hemophilia B
Interventions
GENETIC:
AAV5-hFIXco-Padua
BIOLOGICAL:
Factor IX (FIX)
Sponsor
CSL Behring